 |
Supplements |
RDA/AI
|
Function
|
Upper Limits*/CRN Upper Limits**
|
Dosage for Additional Benefits
|
Health Benefits/Role
|
|
 |
|
|
 | • L-Carnitine and related compounds are involved in transport of long-chain fatty acids into the mitochondria for oxidation. These reactions produce energy |
|
|
| As recommended by your healthcare professional |
|
|
|
|
|
|
| A probiotic which produces lactic acid in the digestive tract |
| May improve gastric motility and digestion |
| Enhances immune function |
| Relieves lactose intolerance |
| Improved mucosal barrier function |
|
|
| 109 to 1010 live bacteria daily |
|
 | Gastrointestinal health | |
|
|
|
|
| Cell metabolism |
| Effective antioxidant (intra-extra-cellular) |
| Regenerates C & E |
|
|
|
| Cognitive function/brain health |
| Diabetes support |
| Nerve function | |
|
|
|
|
| Assists in maintaining water content of cartilage |
|
|
|
| Joint health | |
|
|
|
|
| Source of Vitamin A and D; helps promote healthy bones, organs and nerve function.
|
|
| Vitamin A: 10,000 IU
CRN UL 5,000 IU
|
| Vitamin D: 2000 IU |
|
Vitamin A recommended dose:
5,000 IU
Higher dosing under physician supervision
Vitamin D recommended dose:
600-2,000 IU |
|
| Immune health |
| Bone health |
| Colon health |
| As vitamin A & D supplement |
| Eye Health | |
|
|
|
|
| ATP production |
|
|
|
| Heart health | |
|
|
|
|
| May modulate body composition by reducing fat and may reduce concentrations of blood lipids (cholesterol and triacylglycerol). |
|
|
|
| Weight Management | |
|
|
|
|
| Absorb cholesterol and some types of toxic compounds |
| Stimulates peristalsis |
| Slows gastric emptying |
| May enhance intestinal immune function |
|
|
20-40 gm
It is generally recommended to not exceed 50 gm/fiber daily |
|
| High cholesterol |
| Diabetes support |
| Heart health |
| Gastrointestinal health | |
|
|
|
|
| Omega-3 fatty acid sources |
| Anti-inflammatory actions |
| Inhibit platelet aggregation |
|
|
|
| Skin health |
| Inflammation |
| Heart health |
| High triglyceride |
| Joint health |
| Mood/stress | |
|
|
|
| Alpha-linolenic acid (ALA) |
| 1.6 g (m) |
| 1.1 g (f) |
|
| Omega-3 fatty acid sources |
| Anti-inflammatory actions |
| Inhibit platelet aggregation |
|
|
|
| Skin health |
| Inflammation |
| Heart health | |
|
|
|
|
| Essential component of connective tissue
|
| Required for joint health |
|
|
|
| Joint health | |
|
|
|
|
| Dried kelp is rich in iodine. Iodine is important in numerous biological functions such as thyroid hormones.
|
| Kelp contains 62,400 mcg of iodine /100g.
|
|
|
|
| Healthy Metabolism | |
|
|
|
|
| Semi-essential amino acid |
| involved in urea cycle, synthesis of creatine, and production of agmatine |
|
|
| As recommended by your healthcare professional |
|
| N/A | |
|
|
|
Female:
1.2-2.4g
Male:
1.2-2.4g |
|
| Precursor to choline |
|
Female:
1.2-2.4g
Male:
1.2-2.4g |
|
|
| Cognitive function/brain health | |
|
|
|
|
| Collagen formation (works with vitamin C) |
|
|
|
| Skin health | |
|
|
|
|
| Increases alpha-brain wave activity |
|
|
| As recommended by your healthcare professional |
|
|
|
|
|
|
| Carotenoid |
| Potent antioxidant activity |
|
|
|
| Prostate health | |
|
|
|
|
| A hormone that has a hypnotic effect. May be used in the treatment of some sleep disturbances and insomnia.
|
| At high doses may have antioxidant properties.
|
|
|
| For sleep disturbance or jet lag no more than 0.3 to 3 mg of melatonin should be taken at bedtime and it should not be taken for longer than 2 weeks. Higher doses or for prolonged periods should be done under medical supervision.
Information regarding the precise dose of melatonin is insufficient. Reported dose range has been from 0.3 to 80 mg, but the correct timing of the dose is unclear
|
|
| Sleep promotion | |
|
|
|
|
| Dietary source of sulfur
|
| Essential to connective tissue and joint health |
|
|
1500-6000 mg
doses 6000 mg or higher may have minor side effects |
|
| Anti-inflammatory |
| Joint health | |
|
|
|
|
| • N-Acetyl-L-Cysteine can be a precursor to intracellular glutathione. Glutathione is an antioxidant tripeptide that protects cells from reactive oxygen species. |
|
|
| As recommended by your healthcare professional |
|
|
|
|
|
| US AI Pantothenic Acid 5 mg/day. UK Guidance Level 200 mg/day. |
|
| Pantethine is a metabolically active form of pantothenic acid (vitamin B5). |
| Pantethine is a precursor to Coenzyme A (CoA), which is involved in more than 70 enzymatic reactions. |
| CoA is a cofactor in fatty acid oxidation, carbohydrate metabolism, pyruvate degradation, amino acid catabolism, heme synthesis, acetylcholine synthesis, and phase II detoxification acetylation. The metabolic activity of pantethine may be due to its relationship to CoA. |
| Large doses of pantethine (600 to 1200 mg/day) have lipid-lowering activity. |
|
| CRN UL Pantothenic Acid 1000 mg. |
|
| Most of the clinical trial testing has been 600 to 1200 mg/day, divided across the day in 300 mg doses. |
|
| High cholesterol |
| Diabetes support |
| High triglyceride | |
|
|
|
|
| General antioxidant |
| Fills nutrient gaps |
|
|
| As recommended by healthcare professional |
|
| Immune health | |
|
|
|
|
| Decrease absorption of cholesterol in the gut |
|
|
|
| High cholesterol |
| Heart health | |
|
|
|
|
| Methyl donor
|
| Transmethylation
|
| Aminopropylation
|
| Transulfuration |
|
|
|
| Joint health |
| Liver health |
| Mood/stress | |
|
|
|
|
| Regulates calcium-channel blocking activity and voltage-gated sodium channel blocking activity.
|
| Inhibits the acetylcholine release evoked by excitatory amino acids and protects neurons against excitotoxicity.
|
| May play a role in enhancing cerebral flow.
|
| May have possible antioxidant activity equivalent to vitamin E, reducing neural damages in pathological situations.
|
| Increases brain glucose concentrations.
|
| Provides oxygen for neurons |
|
|
| Typical doses are from 5 mg to 10 mg/day taken with food. Some doses are up to 20 mg/day. Higher doses are not advised.
|
|
| Cognitive function/brain health | |
|
back to top
|
Educational Tools
Print this page
